NVP-ACC789

CAS : 300842-64-2

Ref. 3D-AMA84264

Informations sur le produit

• Nom: NVP-ACC789
• Marque: Biosynth
• Description: NVP-ACC789 is a protein kinase inhibitor that inhibits the activity of the vascular endothelial growth factor receptor (VEGFR). It has been shown to be effective against cancer-related genes and tumor cells in animal models. The drug is also being monitored for adverse effects in humans. The drug can be administered orally or intravenously. NVP-ACC789 has an effective dose of 100 mg per day and can be used as a single agent or combined with other drugs such as nitrosourea.

Propriétés chimiques

• Masse moléculaire: 405.29 g/mol
• Formule: C₂₁H₁₇BrN₄
• Degré de pureté: Min. 95%